Orion Oyj (0M2N.L)
- Globe Newswire
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS27 JANUARY 2022 at 15.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly or indirectly by BlackRock, Inc. and its funds decreased on 26 January 2022 below five (5) per cent of Orion Corporation’s to
- Globe Newswire
Orion publishes Financial Statement Release for 2021 on Thursday 10 February 2022
ORION CORPORATION PRESS RELEASE 20 January 2022 at 14.30 EET Orion publishes Financial Statement Release for 2021 on Thursday 10 February 2022 Orion will publish Financial Statement Release for 2021 on Thursday, 10 February 2022 at approximately 12.00 noon EET. The release and related presentation material will be available on the company’s website at www.orion.fi/en/investors after publishing. Webcast and conference call A webcast and a conference call for analysts, investors and media will be
- Globe Newswire
Orion Corporation and CuraTeQ Biologics expand their biosimilar distribution agreement in Europe
ORION CORPORATION PRESS RELEASE 11 JANUARY 2022 at 8.00 EET Orion Corporation and CuraTeQ Biologics expand their biosimilar distribution agreement in Europe Orion Corporation (“Orion”) and CuraTeQ Biologics Private Limited (“CuraTeQ”), a wholly-owned subsidiary of Aurobindo Pharma Ltd., have expanded their biosimilar distribution agreement to the Baltic countries. The original marketing and distribution agreement signed in 2020 covered the Nordics, Austria, Hungary and Slovenia. Under the agreem
